FDA Director Dr. Peter Marks Admits Expediting Approval of Pfizer COVID Vaccine, Potentially to Meet Mandate Deadlines
The Select Subcommittee on the Coronavirus Pandemic held a pivotal hearing on Thursday titled “Assessing America’s Vaccine Safety Systems, Part One,” where the Director of the FDA’s Center for Biologics Evaluation and Research, Dr. Peter Marks, faced intense questioning over the rapid approval of the Pfizer-BioNTech COVID-19 vaccine.
The hearing, overseen by Chairman Rep. Brad Wenstrup (R-Ohio), probed the effectiveness of the vaccine safety reporting system, as well as the compensation process for vaccine-related injuries.
During the hearing, Rep. James Comer questioned Dr. Marks regarding the timeline for Pfizer’s vaccine approval.
During the hearing, Rep. James Comer questioned Dr. Marks regarding the timeline for Pfizer’s vaccine approval. Dr. Marks admitted that the original deadline was set for January 18,
